[Treatment in initial stage of VTEC infection].
Verocytotoxin producing Escherichia coli(VTEC) causes gastrointestinal infections worldwide. In at most 8% of the children in Japan who are infected with VTEC, hemolytic-uremic syndrome(HUS) develops soon after the onset of diarrhea. Treatment with antibiotics does not ameliorate VTEC infections, and in some studies from western countries, it has been associated with worse clinical outcomes. It was recently indicated in Japan that early administration of fosfomycin to the patients with VTEC infection can decrease the risk of HUS. Moreover, early administration of Synsorb-Pk with high affinity to verocytotoxin to the patients with gastrointestinal VTEC infection was demonstrated to decrease the incidence of very mild and mild HUS, but it did not decrease the risk of moderate and severe HUS. In the developing stage of HUS, intravenous administration of fluid and electrolytes should be determined cautiously to prevent hyponatremia and systemic congestion.
Igarashi
Takashi
T
Department of Pediatrics, Graduate School of Medicine, University of Tokyo.
D000818:Animals; D004573:Electrolytes / Q000008:administration & dosage; D004927:Escherichia coli Infections; D019453:Escherichia coli O157; D005440:Fluid Therapy; D005578:Fosfomycin / Q000008:administration & dosage; D005759:Gastroenteritis / Q000150:complications / Q000382:microbiology* / Q000628:therapy*; D006463:Hemolytic-Uremic Syndrome / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D007010:Hyponatremia / Q000209:etiology / Q000517:prevention & control; D017646:Organosilicon Compounds / Q000008:administration & dosage; D012306:Risk; D014312:Trisaccharides / Q000008:administration & dosage
D004573:Electrolytes; D017646:Organosilicon Compounds; C119238:SYNSORB Pk; D014312:Trisaccharides; D005578:Fosfomycin